The assurance comes as India's Covid graph dips -- on Friday 1,109 new coronavirus infections were reported -- and also one case of a new Covid strain in Mumbai.
The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials.
The Subject Expert Committee on COVID-19 of the CDSCO on October 12 after deliberating Bharat Biotech's EUA application had recommended granting emergency use approval to Covaxin for use in the 12-18 years age group with certain conditions.
'Between its natural immunity with Delta, in so many populations, and then getting on top of the vaccination (situation), I do not think India is going to have another bad wave.'
'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'
A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.
Dr Mishra further explained the effect of hybrid immunity on the vaccinated population and said that it is likely to give protection to people along with the Indian vaccines administered.
Why did the Chinese military take over the lab in Wuhan in end January? Did something go wrong? Claude Arpi glances at the mystery surrounding the origin of the coronavirus.
The United States intelligence community has failed to reach any firm conclusion on the exact origin of COVID-19 and is split on whether it leaked from a lab in China or emerged in nature, even though it does not believe the virus was developed as a biological weapon, according to results of a detailed review ordered by President Joe Biden.
Is the worst of the Covid crisis behind India? As cases dip three weeks after Diwali, the answer is a possible yes, say several experts, attributing the downslide to a large section of the population already exposed to the virus during the second wave and a stepped up vaccination campaign.
The biological weapons convention is a non-starter in spite of the efforts of many states in the world for the last five decades mainly because the US is not ready to accept the 'verification protocol' which could allow the formation of some official mechanism for inspections, says Ajay Lele.
Besides the Joint Entrance Exam that we all know of, here are some more that are equally competitive.
The Centre is conducting a study to assess the presence of SARS-CoV-2, or novel coronavirus, in the Ganga as corpses were found dumped in the river during the second Covid wave, and were fished out from districts in Uttar Pradesh and Bihar, officials said.
The court was informed that though the government's affidavit has been filed, it was not on record.
'What does the nation get out of the CBI's fabulous infrastructure? Very little that is useful.'
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
Bhargava is a pioneer in the field of biotechnology in the country.
The key to scoring good marks in the Common University Entrance Test (CUET UG) lies in identifying target courses and then effectively strategising the preparation to achieve the desired goal.
'We must not compromise with the standard, the quality. We don't need to be the first to launch a drug but what we need is a Made in India vaccine that the entire world can rely on'
Intensifying screening of international passengers at airports, asking educational institutions to postpone their public events, and limiting gatherings, meetings, conferences to 500 people, are among the other measures announced by the government.
Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
The Omicron variant carries 'concerning' mutations that may make it more transmissible and allow it to evade immunity, scientists said on Monday, stressing that the one certainty in the uncertainty of the many things unknown is this -- COVID is not a short-term crisis and vaccines are still a critical tool.
The solicitor general said that the PM CARES Fund is a 'voluntary fund'. "It is a public trust. It is a body where you can make voluntary contributions and no budgetary allocations to the NDRF or SDRF are being touched. What has to be spent will be spent," the law officer said.
The pandemic will be over but Covid will be here to stay, the scientists said as Covid numbers begin to ebb in several parts of the world, including India.
The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.
Biotechnology Overseas Associateship 2003-2004
Professionals in this field wear multiple hats irrespective of their credentials -- scientist, researcher, writer, advocate and activist, to name a few.
Apart from the 1.1 crore doses of Covishield being procured from the Serum Institute of India, 55 lakh doses of indigenously developed Covaxin were being obtained from Bharat Biotech, Union Health Secretary Rajesh Bhushan said at a press conference.
Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'
The Delhi High Court Tuesday directed the Centre to respond to a plea by LGBTQ couples who are seeking live streaming of proceedings on a batch of petitions to recognise same-sex marriages under the special, Hindu and foreign marriage laws on the ground that the matter is of great national and Constitutional importance.
The production of Covaxin will increase from the current 10 million doses per month to 60 million-70 million by July-August.
The Omicron variant was first detected in India in Bengaluru with two people testing positive for it comprising a South African national of Indian origin and a doctor.
'The Swedish government would consider who will live, who will not die, in rationing coronavirus healthcare!' 'This means the 'biological age' would supersede the patient's chronological age as a potential guideline,' notes Ambassador M K Bhadrakumar
China's presence in the international dog house is just the kind of opportunity that his opponents must be waiting for, predicts Colonel Anil A Athale (retd).
'This government did not have any plan for safety stocks of essential medicines.'
Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
Applications are invited from Indian Nationals for the award of "DBT-Postdoctoral Fellowship" for Biotechnology and applied biology.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances